Search Results - "Randomized Controlled Trials as Topic/statistics"

Refine Results
  1. 1

    Source: Acta Oncol
    Acta Oncologica, Vol 64 (2025)
    Kristensen, A W, Jensen, K, Jensen, A L, Dalton, S O, Eriksen, J G, Friborg, J & Grau, C 2025, ' Factors associated with participation in a proton therapy clinical trial : a cross-sectional survey of Danish patients with head and neck cancer ', Acta Oncologica, vol. 64, pp. 879-888 . https://doi.org/10.2340/1651-226X.2025.43912
    Kristensen, A W, Jensen, K, Jensen, A L, Dalton, S O, Eriksen, J, Friborg, J & Grau, C 2025, 'Factors associated with participation in a proton therapy clinical trial : a cross-sectional survey of Danish patients with head and neck cancer', Acta Oncologica, vol. 64, pp. 879-888. https://doi.org/10.2340/1651-226X.2025.43912
    Kristensen, A W, Jensen, K, Jensen, A L, Dalton, S O, Eriksen, J G, Friborg, J & Grau, C 2025, 'Factors associated with participation in a proton therapy clinical trial : a cross-sectional survey of Danish patients with head and neck cancer', Acta Oncologica, vol. 64, pp. 879-888. https://doi.org/10.2340/1651-226X.2025.43912

    File Description: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Source: BMC Med Res Methodol
    BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-14 (2024)
    BMC medical research methodology 24(1), 223 (2024). doi:10.1186/s12874-024-02335-x

    File Description: application/pdf

  7. 7
  8. 8

    Source: BMC Med Res Methodol
    BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-16 (2024)
    Hamza, Tasnim; Schwarzer, Guido; Salanti, Georgia (2024). crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression. BMC Medical research methodology, 24(169) BioMed Central 10.1186/s12874-023-02130-0 <http://dx.doi.org/10.1186/s12874-023-02130-0>
    Hamza, Tasnim; Schwarzer, Guido; Salanti, Georgia (2024). crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression. BMC Medical research methodology, 24(1), p. 169. BioMed Central 10.1186/s12874-023-02130-0 <http://dx.doi.org/10.1186/s12874-023-02130-0>

    File Description: application/pdf; pdf

  9. 9

    Authors: Xu, E Vanghelof, J Wang, Y et al.

    Source: BMC Med Res Methodol
    BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-9 (2024)

  10. 10

    Source: BMC Med Res Methodol
    BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-22 (2024)

  11. 11

    Source: Kubesch, N, Gaitonde, S, Petriti, U, Bakker, E, Basu, S, Birks, L E, Aubrun, E, de Vries, S T & Schneider, R 2024, 'Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraints', Clinical and translational science, vol. 17, no. 11, e70072. https://doi.org/10.1111/cts.70072

    File Description: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/39558508; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/957429f4-e23b-418f-94be-55a568e0d90a; info:eu-repo/semantics/altIdentifier/pissn/1752-8054; info:eu-repo/semantics/altIdentifier/eissn/1752-8062

  12. 12
  13. 13

    Source: BMC Med Res Methodol
    BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-17 (2024)
    Riberholt, C G, Olsen, M H, Milan, J B, Hafliðadóttir, S H, Svanholm, J H, Pedersen, E B, Lew, C C H, Asante, M A, Pereira Ribeiro, J, Wagner, V, Kumburegama, B W M B, Lee, Z-Y, Schaug, J P, Madsen, C & Gluud, C 2024, 'Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses-the METSA systematic review', BMC Medical Research Methodology, vol. 24, no. 1, 196. https://doi.org/10.1186/s12874-024-02318-y
    Riberholt, C G, Olsen, M H, Milan, J B, Hafliðadóttir, S H, Svanholm, J H, Pedersen, E B, Lew, C C H, Asante, M A, Pereira Ribeiro, J, Wagner, V, Kumburegama, B W M B, Lee, Z Y, Schaug, J P, Madsen, C & Gluud, C 2024, ' Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses – the METSA systematic review ', BMC Medical Research Methodology, vol. 24, 196 . https://doi.org/10.1186/s12874-024-02318-y

    File Description: application/pdf

  14. 14

    Source: Journal of clinical epidemiology, vol. 139, pp. 340-349

    File Description: application/pdf; text; pdf

  15. 15
  16. 16

    Source: Pediatr Surg Int

  17. 17
  18. 18

    Source: Ann Hematol

    Subject Terms: Aged, 80 and over, Male, Lymphoma, B-Cell, Dose-Response Relationship, Drug, Age Factors, Kaplan-Meier Estimate, Antibiotic Prophylaxis, Middle Aged, Age Factors [MeSH], Aged, 80 and over [MeSH], Lymphoma, B-Cell/drug therapy [MeSH], Aged [MeSH], Aggressive lymphoma, Prednisone/adverse effects [MeSH], Multicenter Studies as Topic/statistics, Progression-Free Survival [MeSH], Clinical Trials, Phase II as Topic/statistics, Cyclophosphamide/adverse effects [MeSH], Diffuse large cell lymphoma, Feasibility Studies [MeSH], Rituximab/administration, Cyclophosphamide/administration, Original Article, Clinical Trials, Phase III as Topic/statistics, Male [MeSH], Rituximab/adverse effects [MeSH], Doxorubicin/administration, Randomized Controlled Trials as Topic/statistics, Elderly patients, Vincristine/administration, Dose-Response Relationship, Drug [MeSH], Antibiotic Prophylaxis [MeSH], Female [MeSH], Doxorubicin/adverse effects [MeSH], Infections, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Lymphoma, B-Cell/mortality [MeSH], Treatment-related mortality, Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Prednisone/administration, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Vincristine/adverse effects [MeSH], Progression-Free Survival, 3. Good health, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Clinical Trials, Phase III as Topic, Doxorubicin, Antineoplastic Combined Chemotherapy Protocols, Feasibility Studies, Humans, Multicenter Studies as Topic, Prednisone, Female, Cyclophosphamide, Aged

  19. 19
  20. 20